Anne Schuind

7.2k citations

76 papers · 4.4k indexed · 2 hit papers · h-index 27

Impact in

Microbiology top 0.5%
- Bacterial Infections and Vaccines
Epidemiology top 0.5%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies
- Influenza Virus Research Studies
- Herpesvirus Infections and Treatments

Papers in

Microbiology 12
- Bacterial Infections and Vaccines 9
Epidemiology 67
- Hepatitis B Virus Studies 23
- Cervical Cancer and HPV Research 22
- Influenza Virus Research Studies 21
- Herpesvirus Infections and Treatments 18
- Pneumonia and Respiratory Infections 12
- Respiratory viral infections research 11

Co-authors: Gary Dubin Cecília Roteli-Martins Eduardo L. Franco Cosette M. Wheeler David Jenkins Diane M. Harper Barbara Romanowski Anna‐Barbara Moscicki
Journals: Vaccine (20 papers)Human Vaccines & Immunotherapeutics (6 papers)Open Forum Infectious Diseases (6 papers)The Journal of Infectious Diseases (5 papers)Human Vaccines (3 papers)
Partner nations: United States Belgium Germany

In The Last Decade

Anne Schuind

76 papers receiving 4.1k citations

Hit Papers

align trajectories log scale

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial 2006 · 1.2k citations

Peers

Countries citing papers authored by Anne Schuind

Since Specialization

Citations

This map shows the geographic impact of Anne Schuind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Schuind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Schuind more than expected).

Fields of papers citing papers by Anne Schuind

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Schuind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Schuind. The network helps show where Anne Schuind may publish in the future.

Co-authors

The 25 scholars most cited alongside Anne Schuind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anne Schuind Line = papers co-authored together Anne Schuind links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study BMC Health Services Research ·Joël Arthur Kiendrébéogo, Г.С. Альжанова, Yossep Manuel Julca-Santos, Km. Anugya Mehta, M. Bona, Vincent Chatelon, Al-Qazzaz Noor Kamal, Anne Schuind, Andrew Clark	2023	4
2	Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age The Pediatric Infectious Disease Journal ·Joon Hyung Kim, Mamadou Dramé, Thanyawee Puthanakit, Nan‐Chang Chiu, Khuanchai Supparatpinyo, Li‐Min Huang, Cheng‐Hsun Chiu, Po‐Yen Chen, Kao‐Pin Hwang, Е.А. Кривчун, Damien Friel, Bruno Salaun, Wayne Woo, David W. Vaughn, Bruce L. Innis, Anne Schuind	2021	7
3	Immune responses to the adjuvanted recombinant zoster vaccine in immunocompromised adults: a comprehensive overview Human Vaccines & Immunotherapeutics ·Alemnew F. Dagnew, Peter Vink, Mamadou Dramé, David O. Willer, Bruno Salaun, Anne Schuind	2021	11
4	The Adjuvanted Recombinant Zoster Vaccine in Adults Aged ≥65 Years Previously Vaccinated With a Live-Attenuated Herpes Zoster Vaccine The Journal of Infectious Diseases ·Alemnew F. Dagnew, Nicola P. Klein, Caroline Hervé, Kelly Sheehi, Emmanuel Di Paolo, James T. Peterson, Bruno Salaun, Anne Schuind	2020	14
5	Non‐neutralizing antibody responses following A(H1N1)pdm09 influenza vaccination with or without AS03 adjuvant system Influenza and Other Respiratory Viruses ·Damien Friel, J. Pellier, Chu Haifeng, Bruno Salaun, Anne Schuind, Ping Li, Karl Walravens, Francis A. Ennis, David W. Vaughn	2020	6
6	Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials Lara D. Veeken ·Alemnew F. Dagnew, Ahmad Sholihul Hadi, Caroline Hervé, Toufik Zahaf, Myron J. Levin, Anne Schuind, (unknown)	2020	42
7	Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials Human Vaccines & Immunotherapeutics ·Rómulo E. Colindres, Valentine Wascotte, Missy Briardy, Джозеф М. Елліс, Caroline Hervé, Joon Hyung Kim, Myron J. Levin, Lidia Oostvogels, Toufik Zahaf, Anne Schuind, Anthony L. Cunningham	2020	27
8	Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial Vaccine ·Opokua Ofori‐Anyinam, Geert Leroux‐Roels, Mamadou Dramé, Annelies Aerssens, Cathy Maes, Arshad Amanullah, Anne Schuind, Ping Li, Varsha Jain, Bruce L. Innis	2017	17
9	Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial BMJ Open ·Agnihotram V. Ramanakumar, Paulo Naud, Cecília Roteli-Martins, Newton Sérgio de Carvalho, Paola Colares de Borba, Júlio César Teixeira, Mark M. Blatter, Anna‐Barbara Moscicki, Diane M. Harper, Barbara Romanowski, Stephen K. Tyring, Brian Ramjattan, Anne Schuind, Gary Dubin, Eduardo L. Franco	2016	27
10	Immunogenicity and Safety of an AS03-Adjuvanted H7N9 Pandemic Influenza Vaccine in a Randomized Trial in Healthy Adults The Journal of Infectious Diseases ·Montserrat Vicente Dinarès, Nathan Segall, Murdo Ferguson, Louise Frenette, Robin Kroll, Damien Friel, Jyoti Soni, Ping Li, Bruce L. Innis, Anne Schuind	2016	37
11	Immunogenicity and safety of an AS03-adjuvanted H5N1 pandemic influenza vaccine in Korean adults: A phase IV, randomized, open-label, controlled study Vaccine ·Patricia Izurieta, Woo Joo Kim, Seong‐Heon Wie, Jacob Lee, Jin Soo Lee, Mamadou Dramé, David W. Vaughn, Anne Schuind	2015	9
12	Prevalence of Human Papillomavirus Infection and Associated Risk Factors in Young Women in Brazil, Canada, and the United States International Journal of Gynecological Pathology ·Cecília Roteli-Martins, Newton Sérgio de Carvalho, Paulo Naud, Júlio César Teixeira, Paola Colares de Borba, Sophie Derchain, Stephen K. Tyring, Stanley A. Gall, Gao Qinghao, Mark M. Blatter, R. Michael Shier, Barbara Romanowski, Wim Quint, 妙子木内, Claudia Martins Galindo, Anne Schuind, Gary Dubin	2011	29
13	Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women Vaccine ·Adria Santos Andrade, Júlio César Teixeira, Cecília Roteli-Martins, Paulo Naud, Dario Golub, Toufik Zahaf, Muhammad Reza Januar, Anne Schuind	2010	125
14	Substantial impact on precancerous lesions and HPV infections through 5.5 years in women vaccinated with the HPV-16/18 L1 VLP AS04 candidate vaccine Cancer Research ·Stanley A. Gall, Júlio César Teixeira, Cosette M. Wheeler, Paulo Naud, Diane M. Harper, Eduardo L. Franco, Wim Quint, Toufik Zahaf, Anne Schuind, David Jenkins	2007	31
15	Abscess at injection site: Case definition and guidelines for collection, analysis, and presentation of immunization safety data Vaccine ·Katrin Kohl, L. Ball, Jane Gidudu, Sandra Jo Hammer, Scott A. Halperin, Paul T. Heath, Renald Hennig, Jerry Labadie, Edward Rothstein, Anne Schuind, Frederick Varricchio, Wikke Walop	2007	17
16	Efficacy of a Bivalent L1 Virus-Like Particle Vaccine in Prevention of Infection With Human Papillomavirus Types 16 and 18 in Young Women: A Randomized, Controlled Trial Obstetrical & Gynecological Survey ·Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler, Daron G. Ferris, David Jenkins, Anne Schuind, Toufik Zahaf, Bruce L. Innis, Paulo Naud, Newton Sérgio de Carvalho, Cecília Roteli-Martins, Marcos Flávio Portela Veras, Mark M. Blatter, 冯勉, Wim Quint, Gary Dubin	2005	12
17	Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial The Lancet ·Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler, Daron G. Ferris, David Jenkins, Anne Schuind, Toufik Zahaf, Bruce L. Innis, Paulo Naud, Newton Sérgio de Carvalho, Cecília Roteli-Martins, Júlio César Teixeira, Mark M. Blatter, Abner Korn, Wim Quint, Gary Dubin Hit paper breakdown →	2004	1188
18	Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age The Journal of Pediatrics ·Heinz-J. Schmitt, Karin Beutel, Anne Schuind, Markus Knuf, R.L. Silva, Чон-Гол Юн, H. Bogaerts, Hans L. Bock, Ralf Clemens	1997	54
19	Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants The Journal of Pediatrics ·Heinz J. Schmitt, Anne Schuind, Markus Knuf, Karin Beutel, H. Schulte-Wissermann, Manfred Gahr, B.O. Jamarei, 健輔町野, W Rauh, H. Bogaerts, Siti Habibatul Jamiyah, Ralf Clemens	1996	68
20	Continuous monitoring of mixed venous oxygen saturation in infants after cardiac surgery Intensive Care Medicine ·Dietmar Schranz, Chung Chee Won, H Oelert, Franz‐Xaver Schmid, Ralf Huth, B. Zimmer, Anne Schuind, Albane Fily, H. Stopfkuchen, 敏行近藤	1989	22

About Anne Schuind

Anne Schuind is a scholar working on Microbiology, Epidemiology, Virology, Toxicology and Health, having authored 76 papers that have together received 4.4k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (23 papers), Cervical Cancer and HPV Research (22 papers), Influenza Virus Research Studies (21 papers), Herpesvirus Infections and Treatments (18 papers), Pneumonia and Respiratory Infections (12 papers), Respiratory viral infections research (11 papers), Bacterial Infections and Vaccines (9 papers) and Vaccine Coverage and Hesitancy (7 papers). The work is most often cited by research in Microbiology (637 citations), Epidemiology (3.5k citations), Health (358 citations), Immunology (875 citations) and Infectious Diseases (489 citations). Anne Schuind has collaborated with scholars based in United States, Belgium and Germany. Frequent co-authors include Gary Dubin, Cecília Roteli-Martins, Eduardo L. Franco, Cosette M. Wheeler, David Jenkins, Diane M. Harper, Barbara Romanowski, Anna‐Barbara Moscicki, Sue Ann Costa Clemens and Toufik Zahaf. Their work appears in journals such as Vaccine, Human Vaccines & Immunotherapeutics, Open Forum Infectious Diseases, The Journal of Infectious Diseases and Human Vaccines.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact